Bone-targeted agents in multiple myeloma

od Nishida, Hiroko
Izdano u Hematol Rep (2018)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review

od Nishida, Hiroko
Izdano u Cancers (Basel) (2021)

Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets

od Nishida, Hiroko, Yamada, Taketo
Izdano u J Oncol (2019)

Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission

od Nishida, Hiroko, Suzuki, Hiroshi, Hori, Masao, Obara, Katsuyuki
Izdano u Leuk Res Rep (2018)

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

od Nishida, Hiroko, Hayashi, Mutsumi, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Izdano u Blood Cancer J (2018)

The Assembly and Maintenance of Heterochromatin Initiated by Transgene Repeats Are Independent of the RNA Interference Pathway in Mammalian Cells

od Wang, Fangwei, Koyama, Naoki, Nishida, Hiroko, Haraguchi, Tokuko, Reith, Walter, Tsukamoto, Toshiro
Izdano 2006

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

od Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Izdano u Cancer Cell Int (2016)

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synt...

od Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yanagawa, Hiroshi, Yamada, Taketo
Izdano u Cancers (Basel) (2019)

Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription

od Yamada, Kohji, Hayashi, Mutsumi, Madokoro, Hiroko, Nishida, Hiroko, Du, Wenlin, Ohnuma, Kei, Sakamoto, Michiie, Morimoto, Chikao, Yamada, Taketo
Izdano 2013